These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31532503)

  • 21. Pediatric pharmacokinetic data: implications for environmental risk assessment for children.
    Ginsberg G; Hattis D; Miller R; Sonawane B
    Pediatrics; 2004 Apr; 113(4 Suppl):973-83. PubMed ID: 15060190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PBPK and its Virtual Populations: the Impact of Physiology on Pediatric Pharmacokinetic Predictions of Tramadol.
    T'jollyn H; Vermeulen A; Van Bocxlaer J
    AAPS J; 2018 Nov; 21(1):8. PubMed ID: 30498862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and evaluation of a generic physiologically based pharmacokinetic model for children.
    Edginton AN; Schmitt W; Willmann S
    Clin Pharmacokinet; 2006; 45(10):1013-34. PubMed ID: 16984214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of biokinetics in risk assessment of drugs and chemicals in children.
    de Zwart LL; Haenen HE; Versantvoort CH; Wolterink G; van Engelen JG; Sips AJ
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):282-309. PubMed ID: 15135209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonidine disposition in children; a population analysis.
    Potts AL; Larsson P; Eksborg S; Warman G; Lönnqvist PA; Anderson BJ
    Paediatr Anaesth; 2007 Oct; 17(10):924-33. PubMed ID: 17767627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics in immature animals: a review.
    Nouws JF
    J Anim Sci; 1992 Nov; 70(11):3627-34. PubMed ID: 1459923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developmental changes in the liver weight- and body weight-normalized clearance of theophylline, phenytoin and cyclosporine in children.
    Kanamori M; Takahashi H; Echizen H
    Int J Clin Pharmacol Ther; 2002 Nov; 40(11):485-92. PubMed ID: 12698985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of cardiovascular drugs in children. Inotropes and vasopressors.
    Steinberg C; Notterman DA
    Clin Pharmacokinet; 1994 Nov; 27(5):345-67. PubMed ID: 7851053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics in infants and children. A reappraisal.
    Kearns GL; Reed MD
    Clin Pharmacokinet; 1989; 17 Suppl 1():29-67. PubMed ID: 2692939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic considerations in gastrointestinal motor disorders.
    Hebbard GS; Sun WM; Bochner F; Horowitz M
    Clin Pharmacokinet; 1995 Jan; 28(1):41-66. PubMed ID: 7712661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic considerations in the use of antivirals in neonates.
    Enioutina EY; Constance JE; Stockmann C; Linakis MW; Yu T; Rower JE; Balch AH; Sherwin CM
    Expert Opin Drug Metab Toxicol; 2015; 11(12):1861-78. PubMed ID: 26535960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in sensitivity of children and adults to chemical toxicity: the NAS panel report.
    Bruckner JV
    Regul Toxicol Pharmacol; 2000 Jun; 31(3):280-5. PubMed ID: 10915586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics in children with chronic kidney disease.
    Schijvens AM; de Wildt SN; Schreuder MF
    Pediatr Nephrol; 2020 Jul; 35(7):1153-1172. PubMed ID: 31375913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacology and therapeutic drug monitoring in neonates and children.
    Loebstein R; Koren G
    Pediatr Rev; 1998 Dec; 19(12):423-8. PubMed ID: 9849072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developmental pharmacology.
    van den Anker JN
    Dev Disabil Res Rev; 2010; 16(3):233-8. PubMed ID: 20981761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental pharmacokinetics of ciclosporin--a population pharmacokinetic study in paediatric renal transplant candidates.
    Fanta S; Jönsson S; Backman JT; Karlsson MO; Hoppu K
    Br J Clin Pharmacol; 2007 Dec; 64(6):772-84. PubMed ID: 17662086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ontogeny and drug metabolism in newborns.
    Dotta A; Chukhlantseva N
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling.
    Bouzom F; Walther B
    Fundam Clin Pharmacol; 2008 Dec; 22(6):579-87. PubMed ID: 19049658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similarities and differences in gastrointestinal physiology between neonates and adults: a physiologically based pharmacokinetic modeling perspective.
    Yu G; Zheng QS; Li GF
    AAPS J; 2014 Nov; 16(6):1162-6. PubMed ID: 25182208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmental pharmacokinetics in pediatric populations.
    Lu H; Rosenbaum S
    J Pediatr Pharmacol Ther; 2014; 19(4):262-76. PubMed ID: 25762871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.